## ACGL: Arch Capital Group Ltd. - XLF: Financial Services

### Executive Summary

No thesis match: MRS_20 -2.6% below STRENGTH zone (4.0-10.0%); PEG 2.24 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-1.8% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($88.84)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 8
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. First Trust Advisors LP Sells 184,847 Shares of Arch Capital Group Ltd. $ACGL**
- Source: MarketBeat | 20251209T093316 | Somewhat-Bullish | Relevance: 98%
-  First Trust Advisors LP reduced its stake in Arch Capital Group Ltd. (NASDAQ:ACGL) by 24.9% during the second quarter, selling 184,847 shares. Following the transaction, the firm now owns 556,501 shares of the insurance provider, valued at approximately $50.67 million. Several other institutional investors have adjusted their holdings in ACGL, and company CFO Francois Morin also sold 8,000 shares in late November.

**2. California Public Employees Retirement System Trims Stock Holdings in Arch Capital Group Ltd. $ACGL**
- Source: MarketBeat | 20251208T094927 | Neutral | Relevance: 98%
-  The California Public Employees Retirement System (CalPERS) significantly reduced its stake in Arch Capital Group Ltd. (NASDAQ:ACGL) by 15.3% in Q2, selling 248,776 shares and retaining 1,378,214 shares valued at $125.49 million. This move comes as CFO Francois Morin also trimmed his position through a sale of 8,000 shares. Despite strong quarterly results, Arch Capital Group currently holds a "Hold" consensus rating from analysts with an average target price of $106.85.

**3. Wall Street Has a Mixed Opinion on Arch Capital (ACGL), Here’s Why**
- Source: Insider Monkey | 20251209T170914 | Neutral | Relevance: 98%
- Arch Capital Group Ltd. (NASDAQ:ACGL) is receiving mixed opinions from Wall Street analysts. Roth MKM lowered its price target due to below-expectation Q3 2025 written premium growth, despite better-than-expected EPS. Conversely, RBC Capital initiated coverage with a Buy rating, anticipating strong underwriting margins and net investment income to offset a top-line slowdown.

**4. Wall Street Has a Mixed Opinion on Arch Capital (ACGL), Here's Why**
- Source: Finviz | 20251209T170750 | Neutral | Relevance: 97%
- Wall Street analysts have a mixed opinion on Arch Capital (ACGL) despite recent price target adjustments. Harry Fong of Roth MKM lowered his price target to $110 while reiterating a Buy rating, citing mixed Q3 2025 earnings where revenue missed expectations but EPS topped forecasts. Conversely, Rowland Mayor of RBC Capital initiated coverage with a Buy rating and a $108 price target, acknowledging a potential top-line slowdown but anticipating strong underwriting margins and growing net investment income to offset it.

**5. Arch Capital Group Ltd. $ACGL Shares Acquired by Amundi**
- Source: MarketBeat | 20251208T090827 | Somewhat-Bullish | Relevance: 96%
-  Amundi increased its stake in Arch Capital Group Ltd. (NASDAQ:ACGL) by 1.4% in the second quarter, now owning 1,707,324 shares valued at $150.9 million. The company reported strong quarterly earnings, significantly beating analyst expectations, and has a consensus "Hold" rating with an average target price of $106.85 from analysts. CFO Francois Morin also recently sold 8,000 shares of ACGL stock.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-02 | Roth Capital | $110 | $125 | -12% |
| 2025-11-17 | Morgan Stanley | $110 | $105 | +5% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-02 | Roth Capital | main | Buy |
| 2025-11-17 | Morgan Stanley | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 3 ($1.62M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 50.9% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 3 / 7 |

**Top Holders:**
- Vanguard Group Inc: 11.7% (-0.2%)
- Blackrock Inc.: 8.9% (-1.4%)
- Artisan Partners Lim: 6.5% (-0.8%)
- BAMCO Inc.: 5.2% (-4.9%)
- State Street Corpora: 4.6% (-1.0%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-1.8% 5d) with bearish MACD, trend may be turning.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 2.24 elevated, pricing in significant growth expectations. Forward P/E 9.9x stretched relative to 1% growth. Quality metrics strong (margin 21%). Balance sheet: strong liquidity (7513000000.0x), $2.2B free cash flow. Insider selling cluster ($1.6M in 90 days), potential headwind. Institutional flow bullish (3 buying vs 7 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $34.3B |
| Beta | 0.45 |
| 52W Range | $82.45 - $97.40 |
| Short Interest | 1.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.24 |
| Forward P/E | 9.9 |
| Current P/E | 10.0 |
| YoY Growth | 0.5% |
| EPS Direction | RISING |

### Technicals

MRS_20 deteriorating from -0.8% to -2.6% (-1.8% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 6.6pp (needs >4.0% for momentum thesis). Long-term uptrend intact (above SMA200 at 1.01x) but short-term weakness (below SMA20). RSI neutral at 53.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -2.57% (CS: 39) | Weak |
| RSI_14 | 52.8 | Neutral |
| MACD Histogram | -0.25 | Bearish |
| vs SMA20 | 0.996x | Below |
| vs SMA50 | 1.019x | Above |
| vs SMA200 | 1.010x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $91.92
- **Stop Loss:** $88.84 (3.4% risk)
- **Target:** $95.00 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 162
- **Position Value:** $14,891.04
- **Portfolio %:** 14.89%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate risk appetite. VIX remains in the mid-range, breadth is moderate, and yield curve is flat but not inverted—indicating standard late-cycle conditions. Upbeat earnings and positive tech momentum are offset by cautious guidance in consumer sectors, suggesting selective positioning is favored.*

### Earnings

**Next:** 2026-02-10 (Est: $2.33)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.25 | $2.77 | +22.9% |
| 2025Q2 | $2.30 | $2.58 | +12.2% |
| 2025Q1 | $1.31 | $1.54 | +17.2% |
| 2024Q4 | $1.80 | $2.26 | +25.5% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*